Association of serum cystatin C level and major adverse cardiovascular events in patients with percutaneous coronary intervention.
Zhibin XiaoAoge RiletuXiaoyu YanQi MengWeiru ZhangNa ZhangChi MaXin GuoJiatong HanHuijuan NieHui DengJing LiuJianping ChenYu DongTianlong LiuPublished in: Cardiovascular diagnosis and therapy (2024)
These results indicated an association between serum cystatin C level and post-PCI MACE in ACS patients.
Keyphrases
- cardiovascular events
- percutaneous coronary intervention
- coronary artery disease
- acute coronary syndrome
- end stage renal disease
- acute myocardial infarction
- st segment elevation myocardial infarction
- antiplatelet therapy
- ejection fraction
- newly diagnosed
- st elevation myocardial infarction
- chronic kidney disease
- coronary artery bypass grafting
- cardiovascular disease
- prognostic factors
- peritoneal dialysis
- atrial fibrillation
- type diabetes
- patient reported outcomes